October 30, 2009 at 16:49 PM EDT
Options In Focus: JP’s Misstep on HGSI?
Human Genome Sciences (HGSI) is cued up for a widely anticipated binary style event Monday morning. The biotech is expected to release “make or break” data related to its lupus drug collaboration with GlaxoSmithKline (GSK). From Barron’s “The Striking Price Daily” column a JPMorgan analyst recommended bullish investors purchase the November 20 / 25 call vertical for $2.20 based on market prices mined from Thursday’s session. By purchasing the
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here